- Lobbying
- Lobbying by Charles River Laboratories
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Remy Brim | Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren See prior filing Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz |
Maya Seiden | Sp. Asst to Cab Sec., WH; Advisor CoS, Energy Dept.; Sp Asst to Sec of Energy; Sen Advisor, Off of Dep. Sec of State; CoS Office of the Dep Sec of State for Management and Res. Sp. Asst to Cab Sec., WH; Advisor CoS, Energy Dept.; Sp Asst to Sec of Energy; Sen Advisor, Off of Dep. Sec of State; CoS Office of the Dep Sec of State for Management and Res. See prior filing Intern, WH Counsels Office; Intern, Rep. Sam Gejdenson; Sp. Asst to Cab Sec., WH; Advisor to CoS, Energy Dept.; Sp Asst to Sec of Energy; Sen Advisor, Off of Dep. Sec of State; CoS Office of the Dep Sec of State for Management and Res. |
Brent Del Monte | Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee |
Walker Roberts | Dep. COS, House Intl. Rel. Comm., Sp. Asst. to Pres. Dep. COS, House Intl. Rel. Comm., Sp. Asst. to Pres. |
John Stone | Counsel, House E&C Cmte, Oversight Subcommittee; Sr. Counsel, House E&C Cmte, Health Subcommittee See prior filing Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
Health & Human Services - Dept of (HHS)
U.S. Senate
U.S. House of Representatives
Type of Issue
Animals
Q3 Report
Lobbying Issues
Agencies Lobbied
State - Dept of (DOS)
Food & Drug Administration (FDA)
Natl Institutes of Health (NIH)
Health & Human Services - Dept of (HHS)
U.S. Senate
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
State - Dept of (DOS)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
U.S. Senate
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
State - Dept of (DOS)
Food & Drug Administration (FDA)
Natl Institutes of Health (NIH)
Health & Human Services - Dept of (HHS)
U.S. Senate
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
State - Dept of (DOS)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
U.S. Senate
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
State - Dept of (DOS)
Food & Drug Administration (FDA)
Natl Institutes of Health (NIH)
Health & Human Services - Dept of (HHS)
U.S. Senate
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
State - Dept of (DOS)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
U.S. Senate
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
State - Dept of (DOS)
Food & Drug Administration (FDA)
Natl Institutes of Health (NIH)
Health & Human Services - Dept of (HHS)
Type of Issue
Lobbying Issues
Agencies Lobbied
State - Dept of (DOS)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Provide strategic counsel and advocacy for issues related to the non-human primate supply chain for research and practical applications of invitro alternatives in research..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate